Vaccines and profit – a test case for stewardship
So… on the day their partners BioNTec announced the success of their vaccine trial, Albert Bourla, the CEO of Pfizer sold $5.6m of shares. How easily does this sit with our sense of business as a force for good? If I were an investor meeting … Continue readingVaccines and profit – a test case for stewardship